ISTH announces launch of new global education initiative in factor XI/XIa inhibition

Contributed by: PR Newswire

Images

PR Newswire associated0

Tags

ISTH

More Like This

PR Newswire associated0

ISTH Releases Evidence-Based Clinical Practice Guideline for Hemophilia Treatment

PR Newswire associated0

Octapharma's continuing dedication to improving the lives of people with rare bleeding disorders to be showcased at ISTH 2024

PR Newswire associated0

World Thrombosis Day raises global awareness of blood clot dangers through actionable initiatives

Sirius Therapeutics Begins Phase 1 Clinical Trial of Next-Generation, Long-Acting Factor XI siRNA Anticoagulant for Treatment of Thromboembolic Disorders

Sirius Therapeutics Announces Submission to Begin First Clinical Trial of Factor XI siRNA, a Long-Acting Next-Generation Anticoagulant for Thromboembolic Disorders

Roche launches three new Factor Xa inhibitor coagulation tests to meet growing patient need

Sirius Therapeutics Announces Promising Phase I Clinical Data from Its Factor XI siRNA, a Long-Acting Next-Generation Anticoagulant for Thromboembolic Disorders

Sirius Therapeutics to Present Data from Its Phase 1 Clinical Trial of Factor XI siRNA, a Long-Acting Next-Generation Anticoagulant for Thromboembolic Disorders at the 66th ASH Annual Meeting and Exposition